Companies /Healthcare

Molina Healthcare Inc

NYSE: MOH Healthcare Plans
$198.75
▼ $3.68 (−1.82%) today
Markets closed · 1:51am ET

Q2 2025 Earnings

Reported Jul 23, 2025, 4:17pm ET · SEC source
$5.48
Miss −0.93%
EPS · est. $5.53
$11.4B
Beat +4.44%
Revenue · est. $10.9B
+9.4%
Beating market
MOH vs S&P since report
2 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−12%−6%0+6%Jul 23Jul 24report 4:17pm ETearnings+0.2%−12.1%
−12%−6%0+6%Jul 23Jul 24earnings+0.2%−12.1%
MOH −12.1%S&P 500 +0.2%
−12%−6%0+6%Jul 23Jul 24report 4:17pm ETearnings+0.1%−12.1%
−12%−6%0+6%Jul 23Jul 24earnings+0.1%−12.1%
MOH −12.1%NASDAQ +0.1%
−14%−7%0Jul 22Jul 31report 4:17pm ETearnings−0.5%−13.7%
−14%−7%0Jul 22Jul 31earnings−0.5%−13.7%
MOH −13.7%S&P 500 −0.5%
−14%−7%0Jul 22Jul 31report 4:17pm ETearnings−0.3%−13.7%
−14%−7%0Jul 22Jul 31earnings−0.3%−13.7%
MOH −13.7%NASDAQ −0.3%
−16.84%
Day of report
+4.30%
Next session
−0.22%
One week
+10.71%
30 days

S&P 500 over the same 30 days: +1.27%.

Did MOH Beat Earnings? Q2 2025 Results

Molina Healthcare delivered a mixed second quarter for 2025, posting strong revenue growth that masked a meaningful earnings shortfall and prompted the company to lower its full-year profit outlook for the second time this year. Revenue climbed 15.7% year over year to $11.43 billion, clearing the $10.94 billion consensus by 4.44%, as new contract wins, acquisitions, and rate increases pushed premium revenue to $10.87 billion. But profitability told a harder story: adjusted EPS of $5.48 came in just below the $5.53 consensus estimate, weighed down by a deteriorating consolidated medical care ratio that widened to 90.4% from 88.6% a year ago, as utilization pressure spread across all three segments. The Marketplace segment was the most acute pressure point, with its MCR jumping to 85.4% from 71.6%, partly due to the ConnectiCare acquisition and prior-year member reconciliations. Analysts have noted the pattern of repeated guidance reductions, and Molina's revised full-year adjusted EPS floor of $19.00, down sharply from an initial $24.50, reinforced those concerns even as premium revenue guidance held firm at approximately $42 billion.

Key Takeaways
  • Premium revenue growth of 15% year over year driven by new contract wins, acquisitions, footprint growth, and rate increases
  • Membership increased by 167,000 to approximately 5.7 million year over year
  • Marketplace membership nearly doubled to 690,000 from 386,000 year over year
  • G&A ratio improved to 6.2% (6.1% adjusted) reflecting one-time items and operating discipline
  • Consolidated MCR deteriorated to 90.4% from 88.6% due to elevated medical cost utilization

“Our second quarter results and revised full year outlook reflect a challenging medical cost trend environment.”

Molina Healthcare CEO, on the earnings call

Forward Guidance & Outlook

Molina revised its full year 2025 guidance downward. Premium revenue guidance is unchanged at approximately $42 billion (~9% growth from 2024). Adjusted EPS guidance was lowered to no less than $19.00 per diluted share, and GAAP EPS to no less than $16.90 per diluted share. The reduction is disproportionately attributed to Marketplace, reflecting updated medical cost trend assumptions for H2 2025. Full year guidance MCR is 90.2% consolidated (Medicaid 90.9%, Medicare 90.0%, Marketplace 85.1%). New store embedded earnings remain at $8.65 per diluted share, reflecting incremental contributions expected between 2026 and 2028 from newly awarded Medicaid and Medicare Duals contracts and recent acquisitions.

MOH YoY Financials

Q2 2025 vs Q2 2024 · SEC filings Q2 2024 Q2 2025
$0$4.0B$8.0B$12.0B$9.9B$11.4BRevenue$434.0M$373.0MOperating Income$301.0M$255.0MNet Income
$0$4.0B$8.0B$12.0BRevenueOperating IncomeNet Income

MOH Revenue by Segment

Medicaid$8.0B
Medicare$1.6B
Marketplace$1.2B
Other$31.0M

Figures from SEC filings and company reports. Not investment advice.